<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02309957</url>
  </required_header>
  <id_info>
    <org_study_id>EAGLE EU Post Market Study</org_study_id>
    <nct_id>NCT02309957</nct_id>
  </id_info>
  <brief_title>EAGLE European Post Market Study</brief_title>
  <acronym>EAGLE</acronym>
  <official_title>Evaluation of an Acellular Osteochondral Graft for Cartilage LEsions (&quot;EAGLE&quot;) European Post Market Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kensey Nash Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kensey Nash Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multi-center, non-randomized, historical controlled, post-market study of
      patients requiring surgical repair of a focal articular cartilage lesion or osteochondral
      defect in the knee.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BioMatrix CRD is a CE marked device that is intended to repair focal articular cartilage
      lesions or osteochondral defects in the knee. BioMatrix CRD™ is a sterile, biphasic,
      bioresorbable scaffold designed to aid in the repair of cartilage and subchondral bone. The
      device serves as a scaffold for cellular and extracellular matrix ingrowth supporting the
      regeneration of cartilage and subchondral bone.

      The purpose of this post-market study is to confirm the safety and performance of the
      BioMatrix CRD for its intended use. Fifty (50) patients will be enrolled at up to 10
      hospitals in Europe. Patients will be followed for 2 years post-operative to examine the rate
      of adverse events associated with the device, track improvement in knee pain and knee
      function over time, and assess the quality of repair tissue.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Implant Failure</measure>
    <time_frame>24 months</time_frame>
    <description>Rate of implant failure resulting in device removal and/or further surgical intervention due to a device related complication</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knee Related Adverse Events</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of repair tissue as assessed by magnetic resonance imaging</measure>
    <time_frame>at 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in knee pain and function as reported by patients on the Knee Injury and Osteoarthritis Outcome Score (KOOS) Questionnaire</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">33</enrollment>
  <condition>Acute Knee Cartilage Injury</condition>
  <condition>Tear of Articular Cartilage of Knee, Current</condition>
  <arm_group>
    <arm_group_label>BioMatrix CRD</arm_group_label>
    <description>All patients will receive BioMatrix CRD to repair an articular cartilage lesion or osteochondral defect.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BioMatrix CRD</intervention_name>
    <arm_group_label>BioMatrix CRD</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Observational study of patients receiving BioMatrix CRD for surgical repair of a focal
        articular cartilage lesion or osteochondral defect in the knee
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pre-procedure KOOS Pain subscale score less than or equal to 70.

          -  ICRS grade 3 or 4 focal articular cartilage lesion on the medial femoral condyle,
             lateral femoral condyle or trochlea, which measures less than or equal to15mm in
             diameter.

          -  Cartilage lesion is amenable to treatment with a single BioMatrix CRD or an
             osteochondral autograft.

        Exclusion Criteria:

          -  Previous cartilage repair procedure (i.e., microfracture, OATS, ACI) at the intended
             implantation site.

          -  Clinically significant (&gt; 5 degrees) varus or valgus malalignment in either knee.

          -  Osteoarthritis in the injured knee.

          -  Inflammatory arthropathy

          -  Osteomyelitis or other active infection in either lower limb.

          -  Cortisone or hyaluronic acid knee injections in the past 3 months

          -  Body mass index greater than 35.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justus Gille, PD Dr med</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Schleswig-Holstein, Campus Lübeck</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Schleswig-Holstein, Campus Lübeck</name>
      <address>
        <city>Lübeck</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Technische Universität München</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität Regensburg</name>
      <address>
        <city>Regensburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Istituto Ortopedico Rizzoli</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center (MUMC+)</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Robert Jones &amp; Agnes Hunt Orthopaedic Hospital</name>
      <address>
        <city>Oswestry</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 2, 2014</study_first_submitted>
  <study_first_submitted_qc>December 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2014</study_first_posted>
  <last_update_submitted>August 2, 2017</last_update_submitted>
  <last_update_submitted_qc>August 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Knee Cartilage Repair, Osteochondral Defects, BioMatrix CRD</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

